What are Some Challenges in Cytotoxicity Testing of Nanomaterials?
One of the main challenges is the unique behavior of nanoparticles. They can interact with assays and their components in unpredictable ways, leading to false positives or negatives. Additionally, nanoparticles may agglomerate, leading to uneven exposure levels. Standardizing protocols and developing reliable methods are essential to overcome these challenges.
